Discrimination between leucine-rich glioma-inactivated 1 antibody encephalitis and gamma-aminobutyric acid B receptor antibody encephalitis based on ResNet18

Visual Computing for Industry, Biomedicine, and Art

Table 1 Clinical characteristics of patients

	LGI1 antibody encephalitis	GABAB receptor antibody encephalitis	p value
Age (year), mean ± SD	58.27 ± 12.62 (n = 64)	52.18 ± 12.19 (n = 17)	0.08^a
Gender (male/female)	44/20	12/5	0.88^b
Weight (kg), mean ± SD	70.28 ± 11.90 (n = 63)^c	70.65 ± 10.06 (n = 17)	0.91^a
Height (cm), mean ± SD	168.56 ± 7.15 (n = 63)^c	169.06 ± 7.35 (n = 17)	0.80^a

^aTwo-sample student test
^bPearson’s χ² test
^cThe weight and height of one patient with LGI1 antibody encephalitis were unknown